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IntroductIon
In brain, the glutamate-glutamine and 
the glutamate-glutamine-GABA cycles are 
essential for efficient glutamatergic and 
GABAergic neurotransmission. The inter-
actions between neurons and astrocytes 
required for the operation of these cycles 
have received considerable attention since 
their discovery (1). In gray matter, gluta-
mate released from glutamatergic neurons 
is mostly taken up into astrocytes (2, 3) 
where it is converted into glutamine which 
is sent back to the neurons for conversion to 
glutamate. This drain of glutamate released 
from neurons to astrocytes is compensated 
for by a flow of glutamine from astrocytes 
to neurons, thus closing the glutamate-
glutamine cycle.
In addition to transcellular cycling, the 
glutamate-glutamine cycle faces losses of 
components, mainly glutamate, by oxida-
tion, which is balanced by the anaplerotic 
synthesis of glutamate and glutamine in 
astrocytes. As shown by Rothman (4) and 
discussed by Hertz (5), in vivo about 85% 
of the glutamate cycles in the glutamate- 
glutamine cycle but 15% is oxidized. 
Oxidation may take place in astrocytes 
and neurons, and under basal conditions 
it does not appear to require glutamate 
dehydrogenase (GDH), a mitochondrial 
enzyme present mainly in astrocytes, as a 
brain-specific-disruption of the gene has 
small effects on brain glutamate levels (6). 
De novo synthesis of glutamate takes place 
in astrocytes thanks to pyruvate carboxylase 
(PC) (7, 8), which is expressed in astrocytes 
but not in neurons (9–11). This process 
generates a new molecule of oxaloacetate, 
which may condense with acetyl-CoA to 
provide net synthesis of α-ketoglutarate, 
from which glutamate can be formed 
by  transamination (12). Subsequently, 
 glutamine will be  synthesized from glu-
tamate via glutamine synthetase, which is 
exclusively present in the cytosol of astro-
cytes (13, 14). However, this general picture 
of the glutamate-glutamine cycle may be 
oversimplified, and there may be important 
variations, at least, during postnatal devel-
opment. Recent metabolic studies in the 
neonatal rat brain have shown that the flow 
of glutamate from neurons to astrocytes 
is negligible when compared to the adult 
brain (15), while, paradoxically, the flow of 
glutamine from astrocytes to neurons is the 
same or even larger than in adults. This may 
suggest that astrocytes are slowly supplying 
glutamine to neurons so as to build up the 
neuronal pools of glutamate, aspartate, and 
N-acetylaspartate (NAA), which are lower 
than in the adult brain (15), and also, that 
a molecule other than glutamate is being 
transferred from neurons to astrocytes.
BraIn aspartate, 
n-acetylaspartate, GlutamIne 
and Glutamate levels, and the 
synthesIs of GlutamIne In VIVo are 
reduced In aralar-defIcIent mIce
Aralar/AGC1/Slc2512 is an isoform of the 
mitochondrial carrier of aspartate-glutamate 
(AGC), a component of the malate-aspartate 
shuttle (MAS) and it is regulated by calcium 
from the external side of the inner mitochon-
drial membrane (16). MAS activity allows 
the reoxidation of cytosolic NADH which is 
required to maintain glycolysis coupled to 
pyruvate oxidation in mitochondria rather 
than lactate formation. Cytosolic calcium 
sensed by EF-hands in the N-terminal exten-
sions of aralar carrier regulates MAS activity 
in neurons (17) and β-cells (18) and Ca2+-
activated respiration in intact neurons (19).
The deficiency in aralar results in a drastic 
fall in brain aspartate and NAA levels, in a fall 
in NAA production by neurons in culture, 
and global hypomyelination both in mice 
(20–22) and humans (23). Hypomyelination 
has been attributed to a lack of neuronal 
NAA which, after transaxonal transport 
and cleavage by aspartoacylase, is required to 
supply acetyl groups to developing oligoden-
drocytes for myelin lipid synthesis (20, 24), 
energy metabolism (25), or other essential 
functions [reviewed in Ref. (22)].
Aralar deficiency also results in a large 
fall in brain glutamine content but only a 
modest decrease in brain glutamate lev-
els, which is not associated to decreases in 
neuronal glutamate content or changes in 
synaptosomal glutamate release (26). None 
of the activities of the three main enzymes 
involved in the glutamine metabolism 
[phosphate-activated glutaminase, GDH, 
and mitochondrial aspartate aminotrans-
ferase (mAST)] are changed in the brain of 
the aralar-KO mice (26). The synthesis of 
glutamate and glutamine in vivo was also 
analyzed in aralar-deficient mice at P18-20 
after labeling with (1,2-13C)acetate or (1-13C)
glucose. Interestingly, labeled glutamine in 
the brain of aralar-KO mice was found to be 
below detection limit, regardless of whether 
(13C
2
)acetate or (1-13C)glucose were used as 
cerebral substrates. These results clearly 
pointed out to a role for neuronal aralar in 
glial glutamine production in mouse brain.
expressIon and functIonal 
relevance of aralar In BraIn 
cells
A decrease in brain glutamine synthesis 
in aralar-KO mice is puzzling, in the face 
of the prominent expression of aralar in 
 neurons rather than in brain astrocytes 
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in the synthesis of glutamine in aralar-KO 
mice (26). On the basis of these results we 
proposed a transcellular traffic of aspartate 
from neurons to astrocytes which is sum-
marized in Figure 1.
l-Aspartate was proposed to act as a 
neurotransmitter (46), but this hypoth-
esis has been largely abandoned. However 
l-aspartate can be taken up in synaptic 
vesicles and exocytotically released form 
nerve terminals (47). Whether this is the 
mechanism utilized for the transcellular 
flux of aspartate from neurons is unknown. 
Another possibility for the traffic of 
aspartate from neurons to astrocytes may 
involve NAA, as the neuronal transporters 
of NAA are well established, as is its uptake 
by astrocytes and subsequent cleavage by 
aspartoacylase to release acetate and aspar-
tate [reviewed in Ref. (22)].
The neuron-to-astrocyte aspartate 
efflux pathway described in Figure 1 may 
provide a means to transfer NADH/NAD+ 
redox potential to astrocyte mitochondria 
an alternative transcellular shuttle system. 
Indeed, aspartate uptake coupled to OAA 
production provides a substrate for cyto-
solic malate dehydrogenase resulting in 
NADH consumption in the cytosol and 
malate formation. As the α-ketoglutarate–
malate carrier is equally represented in neu-
ronal and glial mitochondria (28), aspartate 
utilization in glutamate formation in astro-
cytes will be stoichiometrically related to 
reducing equivalent transfer to mitochon-
dria. In this way, transcellular aspartate 
traffic would result in malate oxidation by 
astrocytic mitochondria. Malate formed in 
astroglial cytosol may be also transferred 
back to neurons, as malate is released to a 
higher extent from cultured astrocytes than 
from cultured neurons (45).
Alternatively, Hertz (5, 48) has suggested 
that aralar/AGC1 in brain astrocytes, even 
at very low levels, could play a role in a 
modified aspartate-malate shuttle to oxi-
dize reducing equivalents in mitochondria. 
In this modified shuttle OGC and AGC1 
are involved in two different functions: the 
OGC, in glutamate formation (as shown 
in Figure 1) and the AGC1 in glutamate 
oxidation.
concludInG remarks
The role of neuronal aspartate as precursor 
of glutamate synthesis in astrocytes explains 
the alterations found in the brains of aralar/
It is currently believed that most of the 
glutamate oxidation occurs in astrocytes 
(4). Indeed, photoreceptors in the retina 
avoid the oxidation of glutamate through 
a tight regulation of the fate of α-KG exerted 
by the NAD+/NADH ratio (34). However, 
glutamate is also oxidized in photorecep-
tors and neurons. For example, under 
hypoglycemia glutamate oxidation takes 
place through the truncated tricarboxylic 
acid cycle and aspartate becomes the end 
product (35–38). The relative importance 
of astrocytes versus neurons in the oxida-
tion of glutamate in the intact brain both 
at rest and in conditions of activation is still 
unknown.
Astrocytes take up aspartate through 
the same plasma membrane transporters 
that take up glutamate and with the same 
affinity (39). In astrocytes, 15N-aspartate 
is rapidly taken up from the medium (40, 
41), and its amino group is transferred to 
glutamate in the aspartate aminotransferase 
reaction, which then gives rise to glutamine. 
The fate of the carbon skeleton of aspar-
tate in astrocytes has been also addressed 
in metabolic studies with U-13C-aspartate. 
The results indicate that after an initial 
transamination, to give rise to oxaloacetate 
and glutamate, oxaloacetate enters the TCA 
and is largely incorporated into glutamine. 
Another large fraction of oxaloacetate is 
converted into lactate through pyruvate 
recycling (42–44). These facts suggested 
that aspartate produced by neurons may 
be required for glutamate and glutamine 
production in astrocytes, at least during 
postnatal development.
To test the role of aspartate in astro-
cytic glutamate and glutamine synthesis, 
astrocytes were incubated in the presence 
of glucose and different amino acids. The 
supply of 50–200 μM aspartate during 1 h 
to astroglial cultures resulted in glutamate 
and glutamine levels significantly higher 
than those obtained with all the other 
amino acids tested including alanine, 
BCAAs (leucine), and GABA, which, in 
fact, did not enhance glutamate or glu-
tamine synthesis. Of note, this effect of 
external aspartate was identical in astro-
cytes derived from wild type or aralar-KO 
mice. These findings showed that aspar-
tate is the main amino-group donor for 
de novo glutamate synthesis in astrocytes 
and explain why the lack of aspartate pro-
duced in neurons causes an impairment 
(26–30). This preferential expression in 
neurons was surprising, as aralar, and also 
citrin/AGC2/Slc25a13, is definitely present 
in cultured astroglia (26, 27, 31) and aralar 
mRNA has been reported to be present in 
brain astrocytes (31, 32). However, whether 
aralar is actually used in astrocytes in cul-
ture is uncertain, as the lack of aralar in cul-
tured astrocytes did not cause the metabolic 
alterations characteristic of its deficiency in 
neurons [increased utilization of external 
pyruvate, decrease in aspartate levels; (26)]. 
So far, the most accurate determination 
of the localization of aralar in brain was 
that obtained by electron microscopy and 
immunogold-particle labeling of neuronal 
and astrocytic mitochondria, especially as 
the specificity of the labeling was contrasted 
with the use of aralar-KO mouse brains. 
These studies showed that neurons con-
tained 94% of the labeled profiles whereas 
glial cells (both astrocytes and oligodendro-
cytes) contained only about 7%, close to the 
background level (26). These data clearly 
indicate that, at the protein level, aralar is 
localized preferentially, if not exclusively, in 
neurons.
role of aspartate In GlutamIne 
synthesIs By astrocytes
The most striking defect in the aralar-
deficient neuron is the complete loss of 
aspartate. In addition, the levels of other 
amino acids which give rise to pyruvate also 
decrease, in response to a failure of MAS 
which results in a limitation in pyruvate 
supply to mitochondria. As the defect in 
glutamine synthesis is necessarily astrocytic, 
a metabolic limitation in the synthesis of 
glutamate and glutamine was suspected to 
happen in brain astrocytes. As the levels of 
α-KG were also maintained in the KO brains, 
the drop in glial glutamate-glutamine syn-
thesis was attributed to a shortage of the 
amino-group donor (26). It is known that 
the de novo glutamate and glutamine pro-
duction in astrocytes requires the supply of 
one or two ammonia groups, respectively, 
and neurons are thought to supply one or 
both (33). This would depend on whether 
glutamate oxidation occurs in astrocytes, 
which would maintain the amino group of 
glutamate in the astroglial cell, or in neu-
rons, which would not. In this case, neurons 
would need to supply two amino groups 
to neighboring astrocytes per newly made 
glutamine.
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AGC1 KO mice, specifically, the impressive 
drop in the synthesis of glutamine. However, 
these findings were obtained at 18–20 days 
postnatal, at a time where the full develop-
ment of the glutamate/glutamine cycle has 
not yet taken place. Further studies in adults 
will be required to fully understand the role 
of this transcellular pathway.
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